Home  >  Products  >  DTNA (dystrobrevin, alpha ) Blocking Peptide (the C terminal of DTNA)(100ug)
DTNA (dystrobrevin, alpha ) Blocking Peptide (the C terminal of DTNA)(100ug)

DTNA (dystrobrevin, alpha ) Blocking Peptide (the C terminal of DTNA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DTNA Antibody (ARP61444_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61444
Size: 100ug
Weight: 49kDa
Gene: 1837
Format: Lyophilized powder
Target: The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
Alternative names: D18S892E; DRP3; DTN; FLJ96209; LVNC1
See Full Product Listings >